These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16370170)

  • 1. [Ganglion curage in prostate cancer].
    Schumacher M; Burkhard FC; Studer UE
    Ann Urol (Paris); 2005 Oct; 39(5):197-202. PubMed ID: 16370170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
    Peneau M; Villers A; Molinié V; Theis D; Soulié M
    Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for pelvic lymphadenectomy in prostate cancer.
    Link RE; Morton RA
    Urol Clin North Am; 2001 Aug; 28(3):491-8. PubMed ID: 11590808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
    BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcome after radical prostatectomy with extended pelvic lymphadenectomy for untreated high-risk clinically localized prostate cancer].
    Tsurusaki T; Yamasaki Y; Maruta S
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):496-504. PubMed ID: 23819361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic node dissection in prostate cancer: extended, limited, or not at all?
    Hyndman ME; Mullins JK; Pavlovich CP
    Curr Opin Urol; 2010 May; 20(3):211-7. PubMed ID: 20224412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
    Lattouf JB; Beri A; Jeschke S; Sega W; Leeb K; Janetschek G
    Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.
    Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE
    Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the morbidity between limited and extended pelvic lymphadenectomy during laparoscopic radical prostatectomy].
    Rousseau B; Doucet L; Perrouin Verbe MA; Papin G; Erauso A; Joulin V; Deruelle C; Valeri A; Fournier G
    Prog Urol; 2014 Feb; 24(2):114-20. PubMed ID: 24485081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
    Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
    Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study.
    Brenot-Rossi I; Bastide C; Garcia S; Dumas S; Esterni B; Pasquier J; Rossi D
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):635-40. PubMed ID: 15747155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.